Published in Ann Pharmacother on May 08, 2007
Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension. BMC Cardiovasc Disord (2012) 0.88
Safety and efficacy of skin patches containing loxoprofen sodium in diabetic patients with overt nephropathy. Clin Exp Nephrol (2013) 0.75
Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med (2014) 6.73
Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA (2002) 6.30
Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet (2006) 4.42
Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study. Ann Intern Med (2013) 4.35
Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA (2003) 4.00
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis. Value Health (2007) 3.93
Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry (2004) 3.71
Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. JAMA (2004) 3.61
Effect of socioeconomic status on treatment and mortality after stroke. Stroke (2002) 3.44
The risk of hip fracture after initiating antihypertensive drugs in the elderly. Arch Intern Med (2012) 3.10
Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report. Value Health (2007) 3.05
Patterns and correlates of linkage to appropriate HIV care after HIV diagnosis in the US Medicaid population. Sex Transm Dis (2013) 2.92
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Ther (2006) 2.86
Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol (2012) 2.82
The frequency and characteristics of dietary supplement recalls in the United States. JAMA Intern Med (2013) 2.81
Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach. CMAJ (2003) 2.59
Reader's guide to critical appraisal of cohort studies: 1. Role and design. BMJ (2005) 2.43
Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors. Kidney Int (2013) 2.42
IScore: a risk score to predict death early after hospitalization for an acute ischemic stroke. Circulation (2011) 2.29
Effectiveness of virtual reality using Wii gaming technology in stroke rehabilitation: a pilot randomized clinical trial and proof of principle. Stroke (2010) 2.28
Continuity of care and patient outcomes after hospital discharge. J Gen Intern Med (2004) 2.26
Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation (2011) 2.17
Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong? J Bone Miner Res (2004) 2.15
Adherence and persistence among chronic myeloid leukemia patients during second-line tyrosine kinase inhibitor treatment. J Manag Care Spec Pharm (2014) 2.03
Incident depression increases medical utilization in Medicaid patients with hypertension. Expert Rev Cardiovasc Ther (2014) 1.96
Association between total duration of breastfeeding and iron deficiency. Pediatrics (2013) 1.93
New fibrate use and acute renal outcomes in elderly adults: a population-based study. Ann Intern Med (2012) 1.91
Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ (2005) 1.84
Cost-of-illness studies : a review of current methods. Pharmacoeconomics (2006) 1.84
Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada. Transplantation (2008) 1.83
Patients' attitudes about living donor transplantation and living donor nephrectomy. Am J Kidney Dis (2003) 1.80
Impact of statin copayments on adherence and medical care utilization and expenditures. Am J Manag Care (2006) 1.77
Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding. BMJ (2005) 1.76
Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression. Med Care (2010) 1.75
Atypical antipsychotics and parkinsonism. Arch Intern Med (2005) 1.66
Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case-control study. Nephrol Dial Transplant (2010) 1.65
The relationship between cow's milk and stores of vitamin D and iron in early childhood. Pediatrics (2012) 1.64
Autoregression as a means of assessing the strength of seasonality in a time series. Popul Health Metr (2003) 1.55
Effect of medication burden on persistent use of lipid-lowering drugs among patients with hypertension. Am J Manag Care (2008) 1.54
Antihypertensive therapy and incidence of type 2 diabetes in an elderly cohort. Diabetes Care (2004) 1.50
Cost-effectiveness of rosuvastatin compared with other statins from a managed care perspective. Value Health (2005) 1.50
Is ramipril really better than other angiotensin-converting enzyme inhibitors after acute myocardial infarction? Am J Cardiol (2006) 1.50
Croup hospitalizations in Ontario: a 14-year time-series analysis. Pediatrics (2005) 1.49
Dental visits to hospital emergency departments by adults receiving Medicaid: assessing their use. J Am Dent Assoc (2002) 1.49
Authors' self-declared financial conflicts of interest do not impact the results of major cardiovascular trials. J Am Coll Cardiol (2013) 1.47
Increasing use of disease modifying drugs for MS in Canada. Can J Neurol Sci (2010) 1.44
Effect of urologists and medical oncologists on treatment of elderly men with Stage IV prostate cancer. Urology (2011) 1.44
Incidence of delirium in older adults newly prescribed lithium or valproate: a population-based cohort study. J Clin Psychiatry (2005) 1.42
Orlistat and acute kidney injury: an analysis of 953 patients. Arch Intern Med (2011) 1.40
Racial variation in the cost-effectiveness of chemotherapy for prostate cancer. Am J Manag Care (2011) 1.39
Epidemiologic features of acute appendicitis in Ontario, Canada. Can J Surg (2003) 1.39
Influenza and pneumonia hospitalizations in Ontario: a time-series analysis. Epidemiol Infect (2004) 1.30
Risk factors and viruses associated with hospitalization due to lower respiratory tract infections in Canadian Inuit children : a case-control study. Pediatr Infect Dis J (2009) 1.27
Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries. Health Qual Life Outcomes (2013) 1.26
Risk modification for diabetic patients. Are other risk factors treated as diligently as glycemia? Can J Clin Pharmacol (2004) 1.24
The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke. Stroke (2012) 1.24
Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid population. Arch Intern Med (2005) 1.24
Center effects in anemia management of dialysis patients. J Am Soc Nephrol (2007) 1.22
Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part I. Value Health (2009) 1.22
Exploring donors' and recipients' attitudes about living donor kidney transplantation. Prog Transplant (2003) 1.22
Improving chronic disease prevention and screening in primary care: results of the BETTER pragmatic cluster randomized controlled trial. BMC Fam Pract (2013) 1.17
Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart J (2008) 1.17
Utilizing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites. Health Serv Res (2007) 1.16
The iScore predicts poor functional outcomes early after hospitalization for an acute ischemic stroke. Stroke (2011) 1.16
A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. Arch Intern Med (2005) 1.16
Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence. BMJ (2003) 1.16
Disparities in access to essential new prescription drugs between non-Hispanic whites, non-Hispanic blacks, and Hispanic whites. Med Care Res Rev (2006) 1.13
Risk of chronic dialysis and death following acute kidney injury. Am J Med (2012) 1.12
Simplicity within complexity: seasonality and predictability of hospital admissions in the province of Ontario 1988-2001, a population-based analysis. BMC Health Serv Res (2005) 1.12
Barriers to self-management of diabetes: a qualitative study among low-income minority diabetics. Ethn Dis (2011) 1.12
Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer. J Am Geriatr Soc (2009) 1.11
Do Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT study. Clin Trials (2013) 1.11
Economic implications of comorbid conditions among Medicaid beneficiaries with COPD. Respir Med (2009) 1.09
Disparity implications of Medicare eligibility criteria for medication therapy management services. Health Serv Res (2010) 1.09
JURaSSiC: accuracy of clinician vs risk score prediction of ischemic stroke outcomes. Neurology (2013) 1.07
Quantification of the Risk of Corticosteroid-induced Diabetes Mellitus Among the Elderly. J Gen Intern Med (2002) 1.06
Geographical variation in opioid prescribing and opioid-related mortality in Ontario. Healthc Q (2011) 1.06
The development of direct-to-consumer prescription drug advertising regulation. Food Drug Law J (2002) 1.06
Antipsychotic use in the elderly: shifting trends and increasing costs. Int J Geriatr Psychiatry (2005) 1.06
Impact of an educational intervention for secondary prevention of myocardial infarction on Medicaid drug use and cost. Am J Manag Care (2004) 1.06
Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study. Clin J Am Soc Nephrol (2010) 1.04
The seasonality of total hospitalizations in Ontario by age and gender: a time series analysis. Can J Public Health (2003) 1.04
From concepts, theory, and evidence of heterogeneity of treatment effects to methodological approaches: a primer. BMC Med Res Methodol (2012) 1.03
Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients: the role of the medical oncologist evaluation. Med Care (2009) 1.02
Stakeholder engagement in patient-centered outcomes research: high-touch or high-tech? Expert Rev Pharmacoecon Outcomes Res (2014) 1.01
Antipsychotic medications and drug-induced movement disorders other than parkinsonism: a population-based cohort study in older adults. J Am Geriatr Soc (2005) 1.00
Medication access through patient assistance programs. Am J Health Syst Pharm (2006) 1.00
Adherence to multiple sclerosis disease-modifying therapies in Ontario is low. Can J Neurol Sci (2011) 1.00
The effect of hospitalization on oral anticoagulation control: a population-based study. Thromb Res (2006) 0.99
Reasons for discharges against medical advice: a qualitative study. Qual Saf Health Care (2010) 0.99
Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram. Pharmacotherapy (2005) 0.99
Drug therapy persistence and stroke recurrence. Am J Manag Care (2006) 0.98
The total economic burden of overactive bladder in the United States: a disease-specific approach. Am J Manag Care (2009) 0.98
Comparison of angiotensin-converting enzyme inhibitors in the treatment of congestive heart failure. Am J Cardiol (2005) 0.97
Risk of acute kidney injury from oral acyclovir: a population-based study. Am J Kidney Dis (2013) 0.96
Prevalence and predictors of low vitamin D concentrations in urban Canadian toddlers. Paediatr Child Health (2011) 0.96
Fourteen-year study of hospital admissions for diverticular disease in Ontario. Can J Gastroenterol (2007) 0.96